Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer

OBJECTIVE: Precision oncology depends on translating molecular data into therapy recommendations. However, with the growing complexity of next-generation sequencing-based tests, clinical interpretation of somatic genomic mutations has evolved into a formidable task. Here, we compared the performance...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ESMO Open
Auteurs principaux: Perakis, Samantha O, Weber, Sabrina, Zhou, Qing, Graf, Ricarda, Hojas, Sabine, Riedl, Jakob M, Gerger, Armin, Dandachi, Nadia, Balic, Marija, Hoefler, Gerald, Schuuring, Ed, Groen, Harry J M, Geigl, Jochen B, Heitzer, Ellen, Speicher, Michael R
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7513637/
https://ncbi.nlm.nih.gov/pubmed/32967919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000872
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires